Lung Cancer Chemo Prevention: Current Research and Strategies


Date
Friday, January 8, 2016 - Sunday, January 8, 2017 12:00 AM   Online, IN

Overview
Lung Cancer Chemo Prevention: Current Research and Strategies

Objectives
At the conclusion of this activity, participants should be able to:
  1. To review the state of the science and previous clinical trials of lung cancer chemoprevention.
  2. To enumerate the role of eicosanoid biology in lung tumorigenesis.
  3. To examine the role of murine models of lung cancer as preclinical experimental models in cancer chemoprevention.
  4. To review results of a newly completed phase 2b clinical trial in lung cancer chemoprevention

Accreditation

Indiana University School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Indiana University School of Medicine (IUSM) must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, and planning committee members participating in an IUSM-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity. The planning committee and those in a position to control the content of this activity have disclosed no relevant financial relationships. 

This CME activity does not have any commercial support.